BPC-157 & TB-500 Blend
A research blend combining BPC-157 and TB-500 (Thymosin Beta-4 fragment) for additive tissue repair effects across tendon, ligament, muscle, and neural tissue.
⚠ Research & Educational Use Only. BPC-157 & TB-500 Blend is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.
- Additive tissue repair activity in tendon and ligament models
- Complementary angiogenic mechanisms (VEGF + NO pathway)
- Combined gut + systemic healing research
- BPC-157 & TB-500 Blend is not FDA-approved for human use. It is a research chemical for scientific study only.
Research At a Glance
- Additive tissue repair activity in tendon and ligament models
- Complementary angiogenic mechanisms (VEGF + NO pathway)
- Combined gut + systemic healing research
- TB-500 adds systemic cell migration promotion
What is BPC-157 & TB-500 Blend?
The BPC-157 & TB-500 Blend combines two of the most studied healing peptides: BPC-157 (Body Protection Compound-157) and TB-500 (the synthetic heptapeptide fragment of Thymosin Beta-4). While both peptides promote tissue repair, they do so through partially distinct mechanisms, suggesting additive rather than redundant effects when combined.
What It Is
- BPC-157: 15-amino acid pentadecapeptide from gastric juice; systemic and local tissue repair via NO pathway, VEGF, and GH receptor upregulation
- TB-500: Thymosin Beta-4 17-23 fragment (LKKTETQ); actin dynamics and VEGF-mediated healing
- Combined for additive repair across musculoskeletal, gastrointestinal, and neural tissue
How It Works
- BPC-157: promotes angiogenesis via NO synthase upregulation and VEGF; heals gut mucosa; upregulates GH receptors
- TB-500: modulates G-actin/F-actin balance enabling cell migration; promotes VEGF-driven angiogenesis; mobilizes CD34+ stem cells
- Overlapping but mechanistically distinct angiogenic pathways produce additive capillarization at repair sites
- In matched tendon healing studies, the combination showed approximately 15% greater tensile strength recovery vs either peptide alone at day 21
Key Research Findings
- Tendon repair: Combination showed additive effects vs single peptides in Achilles tendon transection models
- Neural repair: Both peptides independently accelerate peripheral nerve regeneration; combination data limited
- GI healing: BPC-157 dominates in gut models; TB-500 adds systemic anti-inflammatory support
Dosing From the Literature
- BPC-157: 250-500 mcg subcutaneous
- TB-500: 2-5 mg subcutaneous or intramuscular
- Combined: administered 2-3 times per week
Storage and Handling
- Lyophilised: 2-8 degrees C; 24 months
- Reconstituted: 2-8 degrees C; use within 28 days
Key Research Benefits
Documented effects observed in preclinical and clinical studies on BPC-157 & TB-500 Blend. See all Healing & Recovery peptides for comparison.
Side Effects & Risks
Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports.
Dosing Data from the Literature
Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.
Administration in Research Settings
Standard reconstitution and administration methodology for laboratory research use.
Subcutaneous or intramuscular injection. For localized injury, inject near the target site.
Explore Further
Quick Reference
Research Use Only
This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.